Literature DB >> 22524556

The role of dexamethasone in the treatment of bacterial meningitis - a systematic review.

S Borchorst1, K Møller.   

Abstract

Corticosteroids are used as an adjunct to antibiotics in the treatment of bacterial meningitis in an attempt to attenuate the intrathecal inflammatory response and thereby reduce mortality and morbidity. The purpose of the present paper is to provide a review of clinical studies of corticosteroids in the treatment of bacterial meningitis. Relevant literature was found in PubMed, the Cochrane databases, and references in studies. Forty-four publications of relevance were identified, comprising 29 publications of randomised studies, 10 publications reporting either non- or quasi-randomised studies, and five reporting retrospective studies, and nine meta-analyses. Taken together, dexamethasone treatment may be associated with a lower mortality in adults and fewer neurological and auditory sequelae in adults and children from high-income countries, in particular in adults suffering from pneumococcal meningitis. In contrast, studies conducted in developing countries have yielded less favourable results.
© 2012 The Authors. Acta Anaesthesiologica Scandinavica © 2012 The Acta Anaesthesiologica Scandinavica Foundation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22524556     DOI: 10.1111/j.1399-6576.2012.02698.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  12 in total

Review 1.  Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

Authors:  Howard E Gendelman; Vellareddy Anantharam; Tatiana Bronich; Shivani Ghaisas; Huajun Jin; Anumantha G Kanthasamy; Xinming Liu; JoEllyn McMillan; R Lee Mosley; Balaji Narasimhan; Surya K Mallapragada
Journal:  Nanomedicine       Date:  2015-01-31       Impact factor: 5.307

2.  Dexamethasone for management of neonatal meningitis.

Authors:  Praveen Kumar; Gagan Mahajan
Journal:  Indian J Pediatr       Date:  2013-01-26       Impact factor: 1.967

3.  Outcome of acute bacterial meningitis among children in Kandahar, Afghanistan: A prospective observational cohort study.

Authors:  Bilal Ahmad Rahimi; Niamatullah Ishaq; Ghulam Mohayuddin Mudaser; Walter R Taylor
Journal:  PLoS One       Date:  2022-04-11       Impact factor: 3.240

Review 4.  Corticosteroids for acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Peter McIntyre; Kameshwar Prasad; Diederik van de Beek
Journal:  Cochrane Database Syst Rev       Date:  2015-09-12

Review 5.  Recent advances in our understanding of Streptococcus pneumoniae infection.

Authors:  Charles Feldman; Ronald Anderson
Journal:  F1000Prime Rep       Date:  2014-09-04

6.  Effective immunosuppression with dexamethasone phosphate in the Galleria mellonella larva infection model resulting in enhanced virulence of Escherichia coli and Klebsiella pneumoniae.

Authors:  Miquel Perez Torres; Frances Entwistle; Peter J Coote
Journal:  Med Microbiol Immunol       Date:  2016-02-26       Impact factor: 3.402

7.  The role of adjunctive dexamethasone in the treatment of bacterial meningitis: an updated systematic meta-analysis.

Authors:  Mei Shao; Peng Xu; Jun Liu; Wenyun Liu; Xiujie Wu
Journal:  Patient Prefer Adherence       Date:  2016-07-14       Impact factor: 2.711

8.  Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitis.

Authors:  Leonam G Coutinho; Denis Grandgirard; Stephen L Leib; Lucymara F Agnez-Lima
Journal:  BMC Infect Dis       Date:  2013-07-17       Impact factor: 3.090

Review 9.  Meningitis in HIV-positive patients in sub-Saharan Africa: a review.

Authors:  Jennifer A Veltman; Claire C Bristow; Jeffrey D Klausner
Journal:  J Int AIDS Soc       Date:  2014-10-10       Impact factor: 5.396

10.  Adjunctive dexamethasone therapy in unconfirmed bacterial meningitis in resource limited settings: is it a risk worth taking?

Authors:  Esayas Kebede Gudina; Markos Tesfaye; Aynishet Adane; Kinfe Lemma; Tamiru Shibiru; Andreas Wieser; Hans-Walter Pfister; Matthias Klein
Journal:  BMC Neurol       Date:  2016-08-26       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.